VALORANT player profile · Europe region · Account level 464 · Title “Performative” · 0 profile views
Current rank: IMMORTAL 1 - 90 RR (as of last recorded competitive match, 2026-06-18).
Peak recorded rank: IMMORTAL 1 - 91 RR (reached 2026-06-11).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 173 |
|---|---|
| Win rate | 55.6% (10 W / 8 L over 27 matches with recorded stats) |
| K/D | 1.07 (507 kills / 472 deaths / 105 assists) |
| Average combat score | 3260 |
| Headshot rate | 27.9% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Deathmatch | Lotus | Astra | - | 24/24/1 | 7044 | - |
| 2026-07-18 | Competitive | Haven | Killjoy | L | 6/14/2 | 125 | - |
| 2026-07-17 | Competitive | Haven | Reyna | W | 17/18/7 | 204 | - |
| 2026-07-15 | Competitive | Lotus | Vyse | L | 14/15/5 | 211 | - |
| 2026-07-10 | Swiftplay | Icebox | Chamber | W | 4/6/2 | 150 | - |
| 2026-07-04 | Deathmatch | Sunset | Veto | - | 39/27/6 | 11828 | - |
| 2026-07-04 | Competitive | Sunset | Clove | W | 25/17/4 | 272 | - |
| 2026-07-03 | Deathmatch | Ascent | KAY/O | - | 2/8/0 | 600 | - |
| 2026-06-30 | Competitive | Split | Clove | W | 16/17/7 | 197 | - |
| 2026-06-27 | Competitive | Lotus | Clove | L | 27/20/8 | 347 | - |
| 2026-06-18 | Competitive | Split | - | - | - | - | +17 |
| 2026-06-18 | Competitive | Lotus | - | - | - | - | +16 |
| 2026-06-18 | Team Deathmatch | District | - | - | - | - | +0 |
| 2026-06-18 | Competitive | Pearl | - | - | - | - | +14 |
| 2026-06-18 | Competitive | Pearl | - | - | - | - | +15 |
| 2026-06-18 | Competitive | Split | - | - | - | - | -19 |
| 2026-06-18 | Competitive | Breeze | - | - | - | - | +15 |
| 2026-06-18 | Competitive | Haven | - | - | - | - | +18 |
| 2026-06-18 | Deathmatch | Fracture | - | - | - | - | +0 |
| 2026-06-18 | Deathmatch | Ascent | - | - | - | - | +0 |
Showing 20 of 173 tracked matches. The interactive profile lists all of them.
No penalty records for this player.